This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
Home » AMSA honors Dr. Aubrey Schroeder as the 2019 Distinguished Extension-Industry Service Award winner
The American Meat Science Association (AMSA) announces that Dr. Aubrey Schroeder is the recipient of the 2019 Distinguished Extension-Industry Service Award. The award was established in 1965 to recognize outstanding achievement in meat science extension and service to the industry and is sponsored by the Foundation for Meat & Poultry Research & Education. Schroeder will be honored on Tuesday, June 25, 2019 at an awards banquet during the AMSA 72nd Reciprocal Meat Conference, in Loveland, Colo.
In his 35 years as a professional scientist, Dr. Aubrey L. Schroeder has worked tirelessly to provide his skills, knowledge, and time to bridge the needs of livestock producers, the meat industry and U.S. consumers with the animal health industry’s business of creating new products. Schroeder works at the important intersection of products and regulations that advance meat animal production in terms of health, welfare, and sustainability, while assuring meat quality and safety are maintained for end-users. He worked with academic institutions to oversee and conduct the meat science research to substantiate the efficacy, safety, application and acceptance of use for beta-agonists and immunological castration, and then oversaw the process for regulatory approval. His work is most closely associated with the clinical development programs, and ultimate success, of products like Paylean (ractopamine), Optaflexx (ractopamine) and Improvest, an alternative immunological castration production tool for pork producers.